Anti Human Lambda (goat) FITC

Anti Human Lambda Anti human Lambda antibodies are immunoglobulins specifically designed to target and bind to the lambda light chain of human immunoglobulins. Lambda light chains are one of the two types of light chains found in human antibodies, the other being kappa light chains. These antibodies are valuable tools in research, diagnostics, and therapeutic applications. Structure and Function: Anti human Lambda antibodies are typically monoclonal antibodies produced in laboratory settings through hybridoma technology or recombinant DNA technology. They are engineered to recognize and bind specifically to the lambda light chain of human immunoglobulins, thereby interfering with various biological processes involving these molecules. Applications:

1. Research: Anti human Lambda antibodies are widely used in immunology and cell biology research to study the expression, distribution, and function of lambda light chains in various biological systems. They help researchers investigate immune responses, autoimmune diseases, and antibody-mediated mechanisms.
2. Diagnostics: In clinical diagnostics, these antibodies play a crucial role in assays for detecting and quantifying lambda light chain levels in biological samples. Elevated levels of lambda light chains are associated with certain diseases, including multiple myeloma and other plasma cell disorders. Detection of these abnormal levels can aid in the diagnosis and monitoring of such conditions.
3. Therapeutics: Anti human Lambda antibodies have therapeutic potential in the treatment of diseases involving aberrant lambda light chain production or function. They can be used as targeted agents to selectively deplete cells expressing lambda light chains, such as malignant plasma cells in multiple myeloma, or to modulate immune responses in autoimmune disorders.